The BEVA has welcomed the news, whilst expressing its concern that the drug was suspended without consultation with the veterinary profession in the first place.
Jon Pycock, BEVA President said: "It remains a concern to BEVA that this mechanism was not put in place before the suspension of flunixin was imposed. Contrary to assertions by the VMD, wholesalers were unable to meet the demands of the veterinary profession and clinical use of this medicine was disrupted within 24 hours of the VMD’s initial announcement.
"We are surprised by the Regulator’s lack of awareness of availability in the supply chain and question why there was no consultation with the veterinary sector before the suspension was enacted. The VMD has been aware of this issue since March 2018 and it appears that no contingency was put in place to consider the animal welfare impact of this decision until it was too late."
BEVA Junior Vice President and Specialist in Equine Surgery Tim Mair continued: "Flunixin is a unique medicine in managing pain and sepsis in horses with colic. The VMD appeared to believe that this medicine could be substituted for other veterinary medicines and this is simply not the case. The release of stock from manufacturers is a short-term solution and, looking forward, we would like assurances that the VMD will fast track applications for the modification of product licenses to ensure that equine vets have continued access to these products."
Professor Kate White, Senior Vice President of the Association of Veterinary Anaesthetists added: "Provision of pain relief is essential to maintain animal welfare. The loss of these products would hinder the work of vets working with horses and donkeys and in zoos where they are first line drugs for the management of pain. Use of flunixin in these animals can be undertaken safely with no impact on human health."
Stock of flunixin held by manufacturers will be distributed alongside a ‘caution in use’ letter that will explain the restricted use of this product. BEVA is reminding all equine vets that the horse’s food chain status must be checked when using this product – either using the paper passport or the recently launched chip checker on the central equine database website.
The new chews incorporate Fr3sh technology, which Virbac says cleanses, cools and addresses the digestive causes of bad breath.
According to the company's research, the new chews provide significant daily breath improvement from Day 1 for a full 24 hours1, as well as continued breath improvement over a 2-week period. 90% of owners highlighted an improvement in bad breath following use of the chews1.
Virbac says the product is also scientifically proven to reduce calculus and plaque when given daily.2
Product Manager Claire Lewis said: "With 2 out of 3 pet owners having a least one dog with bad breath3, we are delighted to be able to add new VeggieDent Fr3sh to the Virbac range of oral healthcare products."
For more information, contact your Virbac Territory Manager.
References:
Comments received from the vet nursing students included: "All the staff were really friendly, welcoming and patient and I left feeling like part of the team", and: "I was actively encouraged and supported with my Nursing Progress Log during my time there".
Megan Piper, pictured right, won the award for the most engaged veterinary nursing student on EMS placement. Megan received excellent feedback from her EMS placements and from her rotations. Feedback comments included: "When Megan qualifies she will make an excellent nurse and a very valued member of any team"; "Megan has consistently demonstrated a professional, motivated approach to her work in practice", and: "Our Referral Vets and Clinical Director were all very sad that she has finished her placement with us, and have invited her to come back once she has qualified".
Donaldson’s Vets Maple Street Surgery in Huddersfield won the 2018 veterinary students’ award for outstanding clinical EMS placement. Comments received from students included: "They are an extremely supportive team that are very keen to teach and get the students involved at every opportunity" and: "They are very good at getting students involved and making them feel like part of the team".
Fiona Ridout won the award for the most engaged veterinary student on EMS placement. She had consistently excellent feedback across all her placements and significantly exceeded the RCVS required number of weeks for pre-clinical and clinical EMS. Feedback comments included: "Fiona has been highly motivated and reliable, always keen to help and gain experience"; "Fiona is one of the best students that we've have ever had"; 'Her clinical knowledge improves each time she visits", and: "Interactions from staff and clients have been impressive".
Veronica Roberts, Senior Clinical Fellow in Equine Medicine at the University of Bristol said: "The University of Bristol believes that EMS prizes encourage and acknowledge student learning in a practical ‘real world’ situation, thus supporting the university in its aim to prepare graduates for day one competencies and life-long learning. We are grateful to practices for the invaluable contribution they make towards student education through offering EMS placements."
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "At Zoetis we are dedicated to supporting animal health through a wide range of quality medicines, vaccines, services and education so we are proud to sponsor these important prizes. They enable winning students to choose a preferred academic resource to help support them during their important first years in practice, while the winning practices can be formally thanked for their invaluable commitment and support."
Lynn Jo Ann Davies MRCVS first appeared before the Committee in January 2018 to face a number of charges related to two drink-driving offences, breaching the terms of her undertakings to the College as part of its Health Protocol, and being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016.
Dr Davies admitted all five charges against her and admitted that this meant she was unfit to practise veterinary surgery and that she was guilty of disgraceful conduct in a professional respect. The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
At its first hearing the Committee having considered both aggravating and mitigating circumstances decided to postpone the hearing for six months on the basis of Dr Davies’ entering into a new set of undertakings, including one not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement.
At the second hearing, in July 2018, the Disciplinary Committee resumed its sanction inquiry decision. Dr Davies’ Counsel submitted on her behalf that Dr Davies wished to return to practise and the Committee reviewed her witness statements, documentary proof and medical records that she provided to demonstrate she had complied with the her undertakings given at the last hearing.
Stuart Drummond, Chairing the Committee and speaking on its behalf, said: "Having had the opportunity to see and hear from the respondent when she gave evidence and when she answered the questions put to her, the view formed of her current state of health was favourable. All members of the Committee considered that the account she gave of herself in the witness box was confident and they were reassured by her evidence as to how she now sets about managing her levels of stress and how she reacted to stressful incidents.
"Such concerns as the Committee had about her return to practice concerned her ability to receive support from a third party who would act as a mentor…the Committee therefore requires the Respondent to identify, within a period of one month of today’s date, a veterinary surgeon who would agree to act as her mentor. That mentor would have to be a veterinary surgeon acceptable to the College as someone suitable to act in that capacity and that mentor would have to be approved before the Respondent could resume practice.
"A further requirement of the Committee would be that the Respondent should make a disclosure to any new employer of the fact of her appearances before this Committee in January 2018 and in July 2018 and of the decisions of the Committee in relation to both such hearings. The final requirement of the Committee in this respect is that the respondent should not accept a 'sole charge position' at any time during her employment during this next period of postponement of sanction."
The Committee directed that the hearing be postponed for a further 12 months.
The pack includes a new leaflet written by the dog behaviourist, Gwen Bailey, and supported by Blue Cross, Association of Pet Behaviour Counsellors (APBC), Wood Green, Puppy School, International Cat Care and Cats Protection.
The leaflet explains the signs of firework fears in both dogs and cats, how to keep pets calm and safe while fireworks are going off and the importance of ensuring that puppies become accustomed to loud and sudden noises gradually. It also highlights the benefits of pheromone support with Adaptil Calm Home Diffuser and Feliway CLASSIC Diffuser.
The company has also provided a leaflet holder, wall display, bunting and social media tool kit containing online banners, suggested social media posts, pet owner email text, PR and presentations.
Vouchers will be available for free Adaptil and Feliway for pet owners already purchasing product.
Abigail King, behaviour product manager at Ceva Animal Health said: "Our vibrant new fireworks marketing and display pack will help raise awareness of the signs of firework fears and the preventative measures that owners can carry out at home to help them keep their pets calm and safe during the fireworks season."
To request a copy of the fireworks marketing and display pack, contact your Ceva Animal Health territory manager or telephone 01494 781510.
Moxiclear contains moxidectin and imidacloprid.
In dogs, Moxiclear can be used for the treatment and prevention of flea infestations and as part of a treatment plan for flea allergic dermatitis. It is also indicated for lungworm, ear mites, sarcoptes mites, biting lice, round worm, hookworm, whipworm, skinworm, and prevents heartworm.
In cats, Moxiclear can be used for the treatment and prevention of flea infestation and flea allergic dermatitis, as well as ear mite infestations. It is also indicated for notoedric mange, gastrointestinal nematodes; whipworm, roundworm and hookworm, and for the prevention of heartworm disease.
In ferrets, Moxiclear can be used to treat and prevent flea infestation, and prevent heartworm.
Moxiclear is available for 4kg-40kg dogs, with four pipette fill sizes. Small cats and ferrets weighing less than 4kg are catered for with a 0.4ml pipette. Large cats weighing 4-8kg can be treated with the Moxiclear 0.8ml pipette.
Lorron Bright, Norbrook Product Manager, said: "Moxiclear offers good value, broad-spectrum parasite control for dogs, cats and ferrets. This latest launch provides our customers with an excellent value, alternative choice for a imidacloprid/moxidectin product."
Richard Palmer, Norbrook Global Head of Sales and Marketing, said: "Moxiclear spot-on is the 11th product we have launched in the past three years. Six of the new products are in the companion animal sector as we continue to strengthen our foothold in the growing global companion animal market. Norbrook is committed to delivering a strong new product pipeline, along with our multi-year £50 million investment programme."
Alexander Reiter and Margherita Gracis formed the new editorial team and selected an international collection of leaders in their fields of expertise to contribute to this latest edition.
Alexander said: "This is a timely publication, as veterinary dentistry is a field that continues to grow in importance for the general veterinary practitioner. We found it important to add 'Oral Surgery' to this new edition, as many procedures performed in and around the mouth involve surgical techniques."
The BSAVA Manual of Canine and Feline Dentistry and Oral Surgery, 4th edition, is an accessible source of core information for general small animal veterinary surgeons, nurses/technicians and students interested in developing their theoretical knowledge and practical skills in dentistry and oral surgery.
The manual is now available from the BSAVA website (www.bsava.com/shop), the BSAVA Library (www.bsavalibrary.com/manuals), or by phone: 01452 726700.
Additional credit is given if the display includes a den, and the top ten displays win a luxury chocolate hamper.
Ceva says the aim of the exercise is to highlight preventative steps pet owners can take to manage their pets' firework fears and the benefits of building a den to help calm and reassure dogs during the firework festivities,
Claire Russell, pheromone product manager at Ceva Animal Health, said: "Our display competition is one of the highlights of the veterinary practice year with veterinary professionals creating innovative displays that capture the imagination of their clients and help educate them on the preventative measures that they can adopt at home to help manage their pet’s firework fears."
Ceva has a range of marketing materials for veterinary practices to use in the competition, including waiting room materials.
For further information, contact your local Ceva territory manager.
Working in collaboration with researchers at University of Texas, Southwestern (UTSW) Medical Center, the team has succeeded in using gene editing techniques on dogs to restore the expression of the dystrophin protein that is absent in DMD patients’ muscles to levels that could be life changing.
DMD is the most common, fatal, genetic disease that affects children. The same disorder also occurs in many dog breeds. It is caused by mutations in the gene that encodes dystrophin, a crucial protein that helps protect muscle fibres and the heart when they contract. Patients with the disease produce effectively no dystrophin protein, so their muscles and heart become damaged during contraction, leading to inability to walk, skeletal deformities, breathing problems and heart failure. Patients with DMD have a life expectancy that does not go far beyond their twenties.
Researchers say that this preliminary research, published in Science, demonstrates an approach that could lead to an effective, in principle one-time treatment for DMD for the most common genetic mutations affecting human patients. Through a single intravenous injection, researchers have been able to modify the dystrophin gene in many muscles of the body, including the heart, with the result that some muscles now had almost the normal amounts of dystrophin protein.
The team, led by Eric Olson, Ph.D., professor and chair of the Department of Molecular Biology at UTSW Medical Center and founder and chief science advisor of Exonics Therapeutics, and Richard Piercy, Ph.D., MRCVS, Professor of Comparative Neuromuscular Disease at the RVC, identified a naturally-occurring mutation in the dystrophin gene in a dog brought to the RVC’s Small Animal Referral Hospital.
Working now with relatives of this first dog, the combined group has used a technique called ‘SingleCut CRISPR gene editing’, where the researchers target a specific region of the subject’s own DNA. Harmless viruses encoding the gene-editing protein CRISPR/Cas9 were used to express the enzyme in muscle to cut the dogs’ own DNA at a precise location in the dystrophin gene through use of a molecular guide. The body’s own processes then repair the cut, which results in removing the negative effects of the existing mutation.
The researchers have demonstrated that dogs treated in this way had restored ability to produce large amounts of the dystrophin protein in their muscles and heart, and in the dog with the highest dose, cardiac muscles were found to have restored dystrophin protein to up to 92% of normal amounts after the single treatment.
The team believes this is the first time that this form of gene editing therapy has been conducted after birth in an animal larger than a rodent. With further longer-term research, efficacy and safety testing, it is hoped that this breakthrough will have human application. This treatment may be a significant step toward developing a gene editing therapy to repair genetic mutations for DMD, as well as a range of diseases caused by genetic mutations.
Richard Piercy, Professor of Comparative Neuromuscular Disease at the RVC, said: "Researchers have been looking for an effective and durable treatment for Duchenne muscular dystrophy for many years. This SingleCut gene editing approach, pioneered by Dr. Eric Olson’s group, has the potential to be a one-time treatment that could restore dystrophin protein. It is hugely exciting that through a single intravenous injection we’ve been able successfully to modify the dogs’ own DNA so they start generating dystrophin protein again. There is more work to be done, but with this exciting breakthrough, we feel we are a significant step closer to finding an effective treatment.
"A great many genetic diseases affect humans, dogs and other species - many, like DMD - with tragic consequences and this form of gene editing treatment might well be applicable in many of them. We’re hopeful that we’re paving the way for future research into treating some of the most serious genetic conditions that affect us today."
Your tip could be clinical in nature (perhaps specific to a particular discipline, like monitoring anaesthesia or small furries), or to do with practice management, or dealing with clients, or HR, or, well, anything really.
To enter the competition, login to VetNurse.co.uk and submit your tip in the forum, here.
Just before you press the button to post your tip, you might like to tick the box marked: "EMAIL ME REPLIES TO THIS POST" which appears immediately above the post button. That way, you'll get an email when someone else posts a tip.
Above each post in the forum, there is now a 'Thank You' link, which allows members to express their thanks for sharing something. The five tips that generate the largest number of 'thank yous' by the end of November will win the Amazon vouchers.
VetNurse.co.uk is all about facilitating the sharing of knowledge, ideas and experience. So any tip entered into the competition will also be disseminated, together with the contributor's name, on other social media channels, such as Facebook, Twitter, Linkedin and if you include a photo, on Instagram.
VetNurse.co.uk Arlo Guthrie said: "The competition is really designed to show off the new 'thank you' feature on VetNurse, which allows members to show their appreciation when someone shares something useful with their peers. In due course, we'll be running similar competitions for the most thanked photos and videos uploaded to our galleries. Watch this space."
Sue, an RCVS and European Specialist in Veterinary Dermatalogy and Senior Vice President of the European Society of Dermatology, says the failure to prioritise pain relief is having a "profound effect on the quality of life of both dogs and clients."
Sue is urging vets to think about the impact that pain has on both the dog and owner in cases of OE: "Otitis externa is painful, it’s debilitating, and the degree of discomfort is often underestimated by both the veterinary surgeon and by the client."
Sue also says vets should not underestimate the owner’s concern about pain in their dog. Owners recognise the clinical signs associated with the pain of OE and determine treatment success by their dog recovering from these distressing symptoms.
To help manage the pain associated with OE, Sue recommends a multi-modal approach: "In addition to systemic pain relief, which is really important, a potent topical steroid is really useful to reduce the inflammation inside that dog’s ear, and make it much more comfortable."
Sue also highlights OE treatments which are able to coat the ear canal and stay there long enough to treat the pathogens and provide sustained pain relief: "When you put it into the ear, Osurnia Gel coats the lining of the external ear canal which gives prolonged contact with the lining of the canal to help treat the pathogens inside that dog’s ear."
Elanco says that despite Osurnia entering the market two years ago, some vets are still saving it for difficult cases. Sue said: "Too many vets use this [Osurnia] as a second-line drug and it should be used as a first-line product on the first occasion the dog comes through the door."
To watch the full series of videos and to find out more from Sue Paterson on treating otitis externa in dogs, visit: www.Osurnia.co.uk
Dr Crawford sent the email to his client, Mrs X, on 15 July 2014, the day on which Mrs X’s horse was due for insemination using horse semen supplied from a horse in Germany. However, the semen had arrived without the Intra Trade Certificate, a requirement for intra-EU inseminations, and so Dr Crawford proceeded to contact the Department for the Environment, Food and Rural Affairs (Defra) for alternative authorisation.
Just after 4:30pm on that day, Mrs X received a text from Dr Crawford advising her that he had received authorisation from the AHVLA, and would forward to Mrs X the AHVLA authorisation email. It later transpired that that the email had in fact been fabricated by Dr Crawford using an email that he had previously received from the AHVLA regarding another matter.
Dr Crawford faced the following charges:
Fabricating an e-mail purporting to be from the veterinary officer at the AVHLA, authorising use of semen from a horse for insemination, when in fact he had not received such authorisation.
Dishonesty in relation to the e-mail described above.
His conduct gave rise to spread of infectious disease which had the potential to affect equine animal health and welfare in the region.
Dr Crawford admitted the first two charges, but denied that his actions had given rise to the risk of disease.
The Committee found the first two charges proved, and moved on to determine the facts of the third charge. They took into account that Dr Crawford had received verbal confirmation that the semen was safe, and that the health papers had been stamped accordingly. He had not, however, seen a copy of this certificate and so there was no guarantee that the semen was safe to use at the time he sent the fabricated email. On consideration of the facts, the Committee found this charge proved, as Mrs X’s mare could have been infected and subsequently could have adversely affected equine animal health and welfare in the region.
They also found that his entire course of action had fallen far short of what is expected of a veterinary surgeon, and that it amounted to disgraceful conduct in a professional respect.
When determining sanction, the Committee took into account a number of aggravating factors, namely the risk of injury to animals, an element of pre-meditation, a disregard for the role of the AHVLA, impersonating a fellow veterinary surgeon, and intending to deceive a veterinary surgeon as well as a member of the public.
It did also, however, take into account the mitigating factors – that there was no injury to the animal, and that it was a single isolated incident from which Dr Crawford did not stand to make any financial gain.
The Committee therefore decided to order the Registrar to suspend Dr Crawford’s registration for 12 months.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee did consider whether to remove Dr Crawford from the Register. However, in light of the significant mitigation in this case, the fact that this was an isolated incident in an otherwise unblemished career, together with his acceptance from the outset that he had been dishonest and his assurance that he would never behave in this way again, the Committee decided that in all the circumstances to remove him from the Register would be disproportionate."
Dr Crawford can lodge an appeal with the Privy Council within 28 days of being notified of the Disciplinary Committee's decision.
Zenifel contains synthetic feline facial pheromones which imitate the facial F3 pheromone which has been found to be significantly important when it comes to cats creating areas they feel safe and relaxed in1.
According to the company, Zenifel contains a 48ml vial of the same synthetic F3 feline facial pheromone as the market leader, but, thanks to its own diffusion system and a higher concentration of F3, lasts up to 6 weeks; i.e. 50% longer. This, says Virbac, means that Zenifel is both more economical and more environmentally friendly.
Alongside the launch of the new product, Virbac is offering a practice support pack which includes things you need to create a calm area for feline visitors and promote the benefits of pheromones to pet owners. The company is also running a promotion in which practices could be eligible for a year’s free supply of Zenifel.
For more information, contact your local Virbac Territory Manager.
Reference
Dr Bremner was convicted in 2017 of harassing his ex-wife, and for perverting the course of justice by sending his daughter an e-mail, pressuring her to ask her mother to withdraw the charges against him. He pleaded guilty to both of the charges, saying he did not understand that it was a condition of his bail that he could not contact his ex-wife. He also expressed shame and remorse at his actions, explaining that his behaviour was triggered by extreme anger, grief and stress.
In relation to the charges, the Respondent was committed to prison for 12 months, suspended for 12 months, ordered to comply with a Rehabilitation Activity Requirement within 12 months, and ordered to pay £85 in costs and £115 as a surcharge to pay for victim services.
The Committee found the facts proved based on the certified copy of the certificate of conviction, as well as the Respondent’s admissions to the facts of the charges. It was satisfied that the Respondent brought the profession into disrepute by the seriousness of his convictions. In addition, the Committee regarded the Respondent as having deficient insight and a need to fully accept personal responsibility for his actions and their consequences.
The Committee was also satisfied that the nature of the communications sent by the Respondent which led to the convictions and the breach of bail conditions, coupled with deficient insight amounted to serious professional misconduct and rendered him unfit to practise veterinary surgery.
The Committee considered various mitigating factors including the fact that no actual harm occurred to any animal, there were no concerns raised about the respondent’s practice, that he has a long and unblemished career, and that he showed some insight into his offences which continues to develop.
The Committee also took into account that preventing the Respondent from practicing could mean the loss of jobs for 33 or so employees, which weighed heavily on their decision. The Committee also agreed with the RCVS’s submissions that there was a very low likelihood of repetition of the offending behaviour. Aggravating factors included the emotional harm caused to the Respondent’s ex-wife, and that the harassment was a course of conduct sustained over a period of five months.
Therefore, when taking into account the particulars of this case, the Committee decided to impose a reprimand and warning on the basis that it would be proportionate to maintain public confidence in the profession in light of the serious nature of these charges.
Chitra Karve, chairing the Committee and speaking on its behalf, said: "The Committee was of the view that the conviction for intending to interfere with the course of justice was particularly serious, in light of the need to maintain public confidence in the profession, because it involved a disregard of proper criminal process.
"However, a particular feature of this case is the risk to the jobs of 33 or so employees if the Respondent were to be prevented from practising as a result of the Committee’s imposition of a sanction. It is this mitigating factor which weighed most heavily with the committee and they therefore concluded that both a Reprimand as to this conduct and a Warning as to any future conduct is sufficient and proportionate in this case to meet the need to maintain public confidence in the profession and uphold proper standards."
Mr Bremner has 28 days in which to make an appeal about the Committee’s decision to the Privy Council.
Lottie, an 11-month-old Labrador puppy was found to have a very loud heart murmur during a routine check before being spayed.
An ultrasound revealed that she had several congenital defects. The two major ones were a malformation of her tricuspid valve and a very large defect of the common atrium.
Lottie was referred to the RVC’s cardiothoracic department where she underwent further ultrasound and a CT scan. The team at the RVC, which is led by Dan Brockman, Professor of Small Animal Surgery, had already performed several cutting-edge surgeries, including a world-first treatment to save the life of a dog born with a malformed tricuspid valve.
Repair of the tricuspid valve has only been performed a handful of times and has not been done at the same time as repair of a common atrium.
Lottie’s owners decided to proceed with the operation, which was undertaken at the end of July. Lottie's heart was stopped for the procedure and her circulation maintained with a heart lung machine run by perfusionist Nigel Cross from Great Ormond Street Hospital.
Poppy Bristow, Fellow in Cardiothoracic Surgery at the RVC, said: "Altogether 10 people were involved in her operation and many more for her care before and after surgery, including veterinary specialists, veterinary nurses and veterinary specialists-in-training from surgery, cardiology, anaesthesia and emergency and critical care, as well as Lottie’s referring cardiologist and her local veterinary practice.
"Lottie’s heart was stopped for an hour and a half, with the whole operation taking four hours. Her malformed tricuspid valve was released by cutting its abnormal attachments and artificial chords using Gore-Tex material were placed. Her single atrium was then divided into two using a large patch of Gore-Tex. Lottie has made a good recovery so far and was walking around and eating from the day after her surgery. She was discharged back to her owners after six days and has continued to thrive at home."
Professor Brockman added: "In Lottie, we had a young energetic dog with such a serious and life-limiting heart condition, that we were desperate to try and help her. The repair was complex but incorporated a combination of surgical manoeuvres that we had done before. With careful pre-operative planning and using our previous experience, we were able to design and execute the surgical treatment. It is still ‘early days’ but the initial signs suggest that Lottie is going to enjoy an excellent quality of life, following this operation and, we all hope, a normal lifespan."
The app, which was designed to provide veterinary surgeons, nurses and receptionists with quick access to up-to-date biological data on a wide range of exotic pets, now contains information about 40 different exotic pet species, from Grey Parrots to Sugar Gliders.
Each species entry offers an overview of the pet, details of common conditions, therapeutics and treatment videos.
Mark, pictured right with a Sulcata tortoise said: "There are a wide range of exotic pets that are becoming increasingly popular with pet owners, yet very few vets understandably have advanced knowledge in this niche area. The "Veterinary Care for Exotics" app for vets means vets, vet nurses and receptionists can now have this knowledge at their fingertips, giving them the reassuring back-up they need when presented with more unusual pets."
The app can be downloaded from Google Play and from Apple's app store, priced at £11.99.
For more information contact Mark Rowland: trinitycpd@gmail.com.
John (pictured right) will compete against leading businessmen and women from across the country and a range of industries in the 'Entrepreneur for Good' category, designed to celebrate entrepreneurs that are pioneering ideas and business models to help drive social change.
John founded Burns Pet Nutrition in 1993, with the thinking that a healthy diet is key to managing many of the common health problems seen in pets. In fact, John reckons he's done more for pets with his line of pet food than he could have ever hoped to have achieved in general practice.
In 2008, John set up The Burns Pet Nutrition Foundation - a charity dedicated to improving the lives of people and pets across the UK. Today, the in-house charity is run by a team of six who specialise in everything from one-off donations to grassroots projects.
One such project, Burns by Your Side, helps schoolchildren to improve their literacy and communication skills with the aid of trained volunteers and their companion dogs. The scheme is currently active in over 40 educational settings across parts of Wales and Ireland.
More recently, Burns Pet Nutrition announced a £1M charity donation to mark its 25th year of trading.
John said "I have decided that the company should be a force for good. I want Burns Pet Nutrition to not only be known for our natural pet food, but also for establishing and maintaining a legacy of good causes in the community."
John is in the running to win the Entrepreneur for Good award along with six other Welsh entrepreneurs. The winners will be announced on Thursday 22nd November at a special gala final in Cardiff.
For further information on the awards, please visit, www.greatbritishentrepreneurawards.com.
RCVS Council agreed, in principle, to the sale of Belgravia House and for the College and its London-based staff to move to different premises at its November meeting.
The sale of the building and the move will be overseen by the College’s Estate Strategy Project Board headed by former RCVS President Barry Johnson and including current and former RCVS Council members and RCVS staff.
The RCVS has been based at its current premises in 62-64 Horseferry Road for 25 years, but says it now needs more up-to-date and modern facilities to accommodate a projected increase in the number of staff.
The College says it has considered a number of alternatives, including expanding the current premises by adding or expanding floors. However, due to the fact that the building is in a conservation area, it has become clear that any such expansions would be unlikely to get planning permission from Westminster Council.
Lizzie Lockett, RCVS Chief Executive, said: "For a number of years it has become apparent that it is fast approaching the time at which our current premises will no longer be fit for purpose due to an increase in the number of RCVS staff – something that is projected to continue in the future – the ongoing need to use the building for Disciplinary Hearings, which take over the lion’s share of available meeting space, and the need for better and more modern facilities.
"Even putting our need for increased space on one side, Belgravia House requires major refurbishment in key areas such as air-conditioning and lifts, which would require staff to vacate the premises for up to 18 months, which would be costly and disruptive.
"We are therefore pleased that Council has recognised the need for the College to move somewhere that better reflects our needs and, over the coming months, we will be exploring a number of different options for new premises.
"In parallel to this we have put out an invitation to tender for agents to manage the sale of the building. The plan is for the arrangement to include lease-back so that we have time to find a suitable premises and enabling us to act quickly when we do."
Any organisations that are interested in putting forward a tender to manage the sale of the building should contact Corrie McCann, RCVS Director of Operations, on 020 7202 0724. Responses to tender are required by 30 November 2018.
Photo: Copyright Google 2018
The modules, which have been approved by the European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland, are designed to help vet nurses and clinic staff build the knowledge and confidence to discuss common parasites with pet owners and advise them about prevention, treatment and best practice.
Time spent on the WormWise Academy can be logged for personal CPD training. Participants who complete all the modules will be awarded with a certificate.
Christopher Pennelegion MRCVS, Companion Animal Technical Consultant at Elanco UK & Ireland, said: "Nurses play a key role in educating and encouraging pet owners in the prevention and treatment of parasites in their pets, advising clients on the best approach whilst maintaining their trust. Therefore, we wanted to recognise that by providing specific nurse training.
"We know there’s a lot of sometimes contradictory information out there on parasites so we aim to provide a clear and comprehensive one-stop-shop to gain all the key facts needed to be able to advise clients."
Topics covered by the three modules include:
Module 1: Worms 101 – everything you need to know about the main pet parasites, including a summary of each species, how to spot them and great tips for pet owners on prevention and treatment.
Module 2: Parasite pep-talks – giving you the skills and tools you need to speak to reluctant pet owners about worms, including advice on tactful ways to broach the topic and encourage better worming practice.
Module 3 (for veterinary nurses and reception staff): Myth-busting for better prevention – dispelling some of the common myths around worming.
The Academy is a part of the wider Milbemax 'Be WormWise' campaign, which aims to raise awareness of the importance of ensuring the optimal worming frequency according to the animal’s lifestyle.
All modules are available at MyElanco.co.uk. Module 3 is downloadable for your practice receptionists.
Canergy contains propentofylline, a xanthine derivative which, Virbac says, potentiates the action of adenosine, a molecule found in the body which has a wide range of physiological effects which can be beneficial in the management of various age-related degenerative disease in dogs and cats1.
In particular, Virbac says propentofylline improves peripheral and cerebral vascular blood circulation, and has bronchodilating actions. This helps to increase oxygen supply to organs and muscles, which can result in a positive effect on overall demeanour and energy levels in older dogs.
Canergy is a beef-flavoured tablet which features SmartTab divisible design.
Canergy Product Manager Claire Lewis said: "Growing old should not have to be a barrier to enjoying life, so we are delighted to be able to add Canergy to the Virbac portfolio."
For more information, contact Virbac ob 01359 243243, email: enquiries@virbac.co.uk or visit: www.virbac.co.uk
IMV Technologies is a reproduction biotechnology company which has worked in the field of animal artificial insemination and embryo transfer for over 50 years, with operations in more than 130 countries and subsidiaries in the USA, India, China, Italy and the Netherlands.
The newly-formed IMV Imaging now has over 500 employees, which, it says, will make it better placed to deliver the best quality ultrasound, X-ray and three-dimensional veterinary-specific imaging equipment.
The directors and senior management team from BCF and ECM are remaining to lead IMV Imaging.
Alan Picken, CEO of IMV imaging said: "The merger and creation of IMV imaging is a very exciting development for our companies. Building on our strong legacy, it allows us to deliver a wider portfolio of products and services to our customers worldwide and ultimately to deliver improved animal care.”
There will now be significant changes to the RCVS Council, as follows:
A gradual reduction in the number of elected members of RCVS Council from the current 24 to 13 by the year 2021.
A change of composition to include six lay members and two veterinary nurse members. Furthermore, the number of Council members appointed by each university whose veterinary degree is recognised by the RCVS will be reduced from two to one and Privy Council will no longer be required to appoint members. From 1 July 2020 university membership will undergo further changes as, from then on, veterinary schools will collectively appoint three members in total to serve on Council.
Members of Council will no longer be able to serve more than three consecutive four-year terms of office and, after serving three consecutive terms, they will not be eligible to re-stand as a candidate for two years.
Members of Council may be removed from office if they fail to satisfy any conditions about fitness to be a member, as determined by their peers on Council. If removed from office they will not be eligible to re-stand as a candidate for two years.
Introducing the LRO before the House of Lords last Tuesday, Lord Gardiner of Kimble said: "The proposed changes… reduce the size of Council and revise the balance of membership between vets and non-vets, including veterinary nurses and lay persons. They will bring the RCVS in-line with many other modern-day regulatory bodies and allow for greater efficiency, transparency and accountability to both members and the general public. For all the reasons I have outlined today, I commend the use of Legislative Reform Order to make changes that will benefit the veterinary profession."
The full text of the Legislative Reform Order can be found on www.legislation.gov.uk and the full transcript of the debate in the House of Lords can be found in Hansard Online (https://hansard.parliament.uk).
Professor Stephen May, RCVS President, said: "We have been looking at reform of Council as an issue of some urgency since 2013, in recognition of the fact that, with the formula-driven growth of Council, it was becoming unwieldy, which has an impact on the cost of each meeting and the frequency with which it could reasonably meet.
"This reform has been long in gestation and so we are glad that this has now been approved and that we can look forward to a more modern, agile and efficient governance structure, aimed as always at benefitting the professions, animal owners and animal health and welfare."
One immediate impact of the LRO relates to the results of this year’s RCVS Council election as the Ministerial sign-off now confirms that only the first three candidates (in order of number of votes) will take up their four-year terms at RCVS Day on Friday 13 July 2018. These are Susan Paterson, Mandisa Greene and Neil Smith, all of whom are current members who were re-elected.
The RCVS Veterinary Nurses Council agreed reforms to its own governance last year, including shortening the term of office from four years to three years; introducing a consecutive three-term limit for elected members; and, reducing the size and changing the composition of VN Council to six elected veterinary nurses, two appointed veterinary nurse members, two appointed veterinary surgeon members from RCVS Council, and four appointed lay members.
The company warned last year that Equip Artervac would be out of stock from the end of November 2017 until mid-2018, but says that the re-availability of the vaccine means many vaccinated stallions and teasers should now be able to have their six-monthly booster dose within the normal designated timeframe.
Equip Artervac is indicated for the active immunisation for horses against equine arteritis virus to reduce the clinical signs and shedding of virus in nasal secretions following infection.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
Daniel Calvo Carrasco, an RCVS specialist in Zoo and Wildlife Medicine and a European Specialist in Avian Medicine and Surgery, will be heading up the new service, which opens its doors to patients in January.
Daniel graduated from Universitat Autònoma de Barcelona in 2010. He began his career at first opinion practices in Birmingham and Wiltshire, where he developed his skills as a vet in small animals, while still having the chance to look after small furries from a local pet shop where he was based. He then completed an exotic animal medicine and zoological medicine internship, followed by two years of small animal and exotic practice in the UK.
In May 2016 he gained his RCVS CertAVP(ZooMed) and later that year he completed his European College Zoological Medicine Avian residency.
For the next two years, he worked at Great Western Exotics before joining the Wildfowl & Wetlands Trust in 2018, where he combined conservation work with managing and caring for its living collection.
Daniel said: “I’ve always had a passion for zoological medicine and caring for the more exotic mammals, birds, reptiles and amphibians, and I’m excited to be leading this new service at Southfields.
“I really enjoy all aspects of exotic, zoo and wildlife medicine and have a particularly keen interest in orthopaedics and advanced surgery in exotic species.
“I have treated all sorts of species in my time from parrots and lizards to wading birds such as the Spoon-billed Sandpiper, Aldabra tortoise, Hyacinth Macaw, Toucans, Seriemas and many birds of prey.”
Southfields hospital director Daniel Hogan said: “We are delighted to have recruited Daniel to lead this exciting addition to the services we offer.
“He is highly experienced and will lead our new exotic animal service, which is the first such service in the whole of the South East and will be available 24/7 to offer the best and most comprehensive zoo and wildlife care in the region.”
For more information, visit: https://www.southfields.co.uk/